Short Interest in Novozymes A/S (OTCMKTS:NVZMY) Decreases By 20.1%

Novozymes A/S (OTCMKTS:NVZMY) was the recipient of a large decline in short interest in the month of February. As of February 27th, there was short interest totaling 4,463 shares, a decline of 20.1% from the February 12th total of 5,586 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average trading volume of 305,495 shares, the short-interest ratio is currently 0.0 days. Based on an average trading volume of 305,495 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

Novozymes A/S Stock Performance

NVZMY traded down $0.02 on Friday, hitting $54.51. 215,947 shares of the company traded hands, compared to its average volume of 149,201. Novozymes A/S has a 12-month low of $53.50 and a 12-month high of $75.99. The company has a 50 day moving average of $61.15 and a 200-day moving average of $62.01. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $22.60 billion, a PE ratio of 38.94, a PEG ratio of 0.99 and a beta of 1.11.

Novozymes A/S (OTCMKTS:NVZMY) last announced its earnings results on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.79 by ($0.44). The company had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Novozymes A/S had a net margin of 13.96% and a return on equity of 6.38%. Sell-side analysts anticipate that Novozymes A/S will post 1.82 earnings per share for the current year.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).